Lumida
/CDXS
⌘K
Codexis Inc

Codexis Inc

CDXS
$1.47USD+1.74%+0.03 today

MARKET CAP

160.4M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
TrimMedium

CDXS remains entrenched in a Stage 4 decline under all key moving averages. Medium-term bias is bearish with no active reversal patterns, and short-term oversold support raises bounce risk. Deferred selling on any rally into declining EMA/SMA resistance is advised.

  • Q2 revenue of $14.9M topped $13.8M estimate; 2026 guidance held at $72–76M
  • Gross margin improved to 73%, signaling rising operational efficiency
  • Net loss of $12M (−$0.13/sh) with low earnings yield indicates weak profitability
Full analysis →
Insider Trades7 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 24, 2026SellCDXSStefan LutzChief Scientific Officer5,862$1.13$160.4M-50.84%+52.87%$6.6K-1.30%Stalk
Feb 6, 2026SellCDXSStefan LutzChief Scientific Officer2,492$1.31$160.4M-50.84%+52.87%$3.3K-1.80%Stalk
Feb 6, 2026SellCDXSAlison MoorePresident and CEO3,826$1.31$160.4M-50.84%+52.87%$5.0K-1.50%Stalk
Feb 6, 2026SellCDXSGeorgia Erbez3,826$1.31$160.4M-50.84%+52.87%$5.0K-5.42%Stalk
Jan 7, 2026SellCDXSStefan LutzCSO4,685$1.70$160.4M-50.84%+52.87%$7.9K-3.27%Stalk
Oct 13, 2025SellCDXSGeorgia ErbezChief Financial Officer6,239$2.50$160.4M-50.84%+52.87%$15.6K-8.12%Stalk
Oct 13, 2025SellCDXSAlison MooreChief Technical Officer6,239$2.51$160.4M-50.84%+52.87%$15.6K-3.55%Stalk